Search research articles
Contact Us
Filters
Showing results (101-110 of 104) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 104 results.
Nature Cancer
|
March 1, 2024
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols
Oren Barboy, Akhiad Bercovich, Hanjie Li, et al.
Blood
|
June 20, 2020
Correcting β-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity
Carla Casu, Mariateresa Pettinato, Alison Liu, et al.
Cancer Cell
|
April 11, 2025
ZEB2 is a master switch controlling the tumor-associated macrophage program
Fadi Sheban, Truong San Phan, Ken Xie, et al.
Journal of the American Chemical Society
|
March 13, 2013
A homogeneous chemiluminescent immunoassay method
Hashem Akhavan-Tafti, Dean G Binger, John J Blackwood, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 104) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 104 results.
Nature Cancer
|
March 1, 2024
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols
Oren Barboy, Akhiad Bercovich, Hanjie Li, et al.
Blood
|
June 20, 2020
Correcting β-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity
Carla Casu, Mariateresa Pettinato, Alison Liu, et al.
Cancer Cell
|
April 11, 2025
ZEB2 is a master switch controlling the tumor-associated macrophage program
Fadi Sheban, Truong San Phan, Ken Xie, et al.
Journal of the American Chemical Society
|
March 13, 2013
A homogeneous chemiluminescent immunoassay method
Hashem Akhavan-Tafti, Dean G Binger, John J Blackwood, et al.
Page
of 11